Skip to main content
  • SCOPE I Trial Finds No Clinical Outcome or Failure Differences for ACURATE Neo and SAPIEN 3 Valves at 3 Years

    Differences in procedural outcomes and performance between the ACURATE neo and SAPIEN 3 bioprosthetic valve devices did not translate into significant differences in clinical outcomes or device failure after 3 years.

This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies. Review our Privacy Policy for more details